Pharmacokinetics of pimobendan after oral administration to dogs with myxomatous mitral valve disease

Autor: Anna K. McManamey, Teresa C. DeFrancesco, Kathryn M. Meurs, Mark G. Papich

Publikováno v: Journal of Veterinary Internal Medicine, Vol 37, Iss 6, Pp 2003-2010 (2023)

Abstract Background Pimobendan is an important therapy for dogs with myxomatous mitral valve disease (MMVD). The pharmacokinetics are reported in healthy dogs but not in dogs with heart disease. Hypothesis/Objectives To determine if dog characteristi

Externí odkaz: https://doaj.org/article/b76930fc67a4470687519b2b6d6ed032

Effect of pimobendan on left atrial function in dogs with preclinical myxomatous mitral valve disease

Autor: Fabio Sarcinella, Joao Neves, Thomas W. Maddox, Hannah M. Hodgkiss-Geere, Elizabeth F. Bode, Joanna Dukes-McEwan

Publikováno v: Open Veterinary Journal, Vol 9, Iss 4, Pp 375-383 (2019)

Background: Left atrial (LA) function is an important determinant of left ventricular (LV) filling, playing a key role in maintaining optimal cardiac performance. Pimobendan is a phosphodiesterase III inhibitor with positive inotropic and vasodilator

Externí odkaz: https://doaj.org/article/1a98491750df45dcbc5de015b698fc65

Cardiac Effects of a Single Dose of Pimobendan in Cats With Hypertrophic Cardiomyopathy; A Randomized, Placebo-Controlled, Crossover Study

Autor: Maureen S. Oldach, Yu Ueda, Eric S. Ontiveros, Samantha L. Fousse, Samantha P. Harris, Joshua A. Stern

Publikováno v: Frontiers in Veterinary Science, Vol 6 (2019)

Background: Pimobendan has been shown to impart a significant survival benefit in cardiomyopathic cats who receive it as part of heart failure therapy. However, use of pimobendan remains controversial in cats with hypertrophic cardiomyopathy (HCM) du

Externí odkaz: https://doaj.org/article/fb8f8debcee64668ba03e520679f496f

Effect of pimobendan on left atrial function in dogs with preclinical myxomatous mitral valve disease

Autor: João Neves, Elizabeth F. Bode, Hannah Hodgkiss-Geere, Fabio Sarcinella, Thomas W. Maddox, Joanna Dukes-McEwan

Publikováno v: Open Veterinary Journal; Vol 9, No 4 (2019); 375–383
Open veterinary journal
Open Veterinary Journal, Vol 9, Iss 4, Pp 375-383 (2019)
Open Veterinary Journal

Background: Left atrial (LA) function is an important determinant of the left ventricular (LV) filling, playing a key role in maintaining optimal cardiac performance. Pimobendan is a phosphodiesterase III inhibitor with positiveinotropic and vasodila

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d1855990f365ae1f109cb2b0b63c0cc
https://www.ajol.info/index.php/ovj/article/view/192682

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.